Cough, Cold and Allergy (Hay Fever) Remedies

In 2023, cough, cold and allergy (hay fever) remedies is set to maintain dynamic current value growth in Brazil. In this year, the conclusion of the Public Health Emergency of International Concern (PHEIC) for COVID-19, as declared by the World…

The removal of mask-wearing and social distancing measures in March 2023 led to rising demand for cough, cold and allergy remedies as respiratory infections increased. Since February 2020, local seasonal influenza in Hong Kong has remained at a low…

Cough, cold and allergy (hay fever) remedies continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of Thais to their…

Locally preferred alternatives, like consuming honey, ginger, and lemon infusions, enjoy widespread popularity among the locals. In households with lower incomes, natural remedies often take precedence as the initial choice before resorting to…

On a landscape featuring local and international brands, consumers can access a wide array of choices. Brands like Emzolyn and Exiplon are popular among individuals with lower disposable incomes, while international counterparts, including Benylin,…

A prevalent issue in cough, cold and allergy (hay fever) remedies is the misuse of cough syrups, often through self-medication with OTC products. To address this concern, a regulatory framework has been implemented restricting the distribution of…

Cough and cold remedies were recording see high single-digit growth in current value terms in 2023, with sales benefiting from the large number of cases of cold and flu in the 2023/2024 season. Furthermore, value sales were also being boosted by unit…

Cough, cold and allergy (hay fever) remedies have witnessed stronger growth in 2023, due to warmer weathers and increased time spent out of the home. Warmer weather in Switzerland has led to an increase in pollen and the incidence of allergic…

In 2023, cough, cold, and allergy (hay fever) remedies in India is set to experience moderate single-digit current value growth, driven predominantly by the demand for decongestants. Decongestants is expected to demonstrate above-average growth due…

In line with rising health-consciousness, people in Taiwan are becoming more worried about the potentially hazardous side effects and contraindications of active pharmaceutical ingredients in standard OTC medications. This has continued to buoy…

With an early start to the influenza season, many New Zealanders were caught off guard and succumbed to the virus throughout 2023. With a dry cough being one of the most common flu symptoms, demand for treatments to help soothe the throat was…

Cough, cold and allergy (hay fever) remedies received a strong sales boost in 2022 due to consumers returning to working in the office more frequently again and kids returning to in-school classes. This led to consumers spending more time among other…

The pandemic brought about a huge increase in sales of cough, cold and allergy (hay fever) remedies, especially from the end of 2021, with later COVID-19 variants being revealed to have unique symptoms resembling those of the common cold. In February…

In the Philippines, one interesting aspect of OTC products in general and cough, cold and allergy (hay fever) remedies in particular is that consumers are generally very aware of the active ingredients that are contained within these products and the…

During the review period, the flu and allergy season in South Africa was rife specifically during the winter periods. Given the presence of several flu strains and allergies, consumers reached out to cough, cold and allergy (hay fever) products to…

Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…

Cough, cold and allergy (hay fever) remedies witnessed an improved performance in constant value terms in 2023. This was due, in a large part, to a return of pre-pandemic lifestyles, including the reopening of schools and workspaces, which…

In early 2023, a sixth wave of COVID-19 coincided with an upsurge in cases of the common cold and influenza, creating a "tripledemic" felt across Mexico, the US, and Central American countries, with Mexico experiencing a milder impact. This scenario…

Cough, cold and allergy remedies face favourable growth in 2023, with the category boosted by the return to normal social lifestyles post-pandemic. The regular circulation of seasonal cold viruses is fuelling demand, which had previously fallen due…

With value sales of cough and cold and allergy ( hay fever) remedies reducing to more normal levels. as concern about COVID-19 abate, there is expected to be a decline in volume sales in 2023. The exception being medicated confectionery. Along with…